secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001558370-23-001767
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q4 net sales $71.2M, down 3% YoY; full-year net loss $99.2M; guides 2023 sales $290-295M
--------------------------------------------------------------------------------

- Q4 net sales $71.2M (-3% YoY); glaucoma $52.9M, corneal health $18.3M.
- Q4 GAAP net loss $31.5M ($0.66/sh); non-GAAP net loss $25.1M ($0.53/sh).
- Full-year 2022 net sales $282.9M (-4% YoY); net loss $99.2M ($2.09/sh).
- 2023 net sales guidance $290M-$295M; cash & equivalents $360M.
- R&D expenses rose 34% in Q4 to $35.8M; SG&A up 9% to $51.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000155837023001767/0001558370-23-001767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000155837023001767/gkos-20230222x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-001767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer